“Indacaterol/ Glycopyrronium in Symptomatic Patients with COPD (GOLD 2 and GOLD 3) Versus Salmeterol/ Fluticasone”, IJBR, vol. 3, no. 4, pp. 614–617, Apr. 2025, doi: 10.70749/ijbr.v3i4.859.